Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) Cost of Revenue (2019 - 2025)

GoHealth's Cost of Revenue history spans 7 years, with the latest figure at $20.1 million for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 2.09% year-over-year to $20.1 million; the TTM value through Sep 2025 reached $144.0 million, up 20.55%, while the annual FY2024 figure was $130.6 million, 17.83% down from the prior year.
  • Cost of Revenue for Q3 2025 was $20.1 million at GoHealth, down from $32.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $99.9 million in Q4 2021 and bottomed at $19.7 million in Q3 2024.
  • The 5-year median for Cost of Revenue is $39.3 million (2025), against an average of $42.5 million.
  • The largest annual shift saw Cost of Revenue surged 107.66% in 2021 before it crashed 79.35% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $99.9 million in 2021, then plummeted by 79.35% to $20.6 million in 2022, then surged by 99.16% to $41.1 million in 2023, then rose by 27.14% to $52.2 million in 2024, then crashed by 61.53% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Cost of Revenue are $20.1 million (Q3 2025), $32.4 million (Q2 2025), and $39.3 million (Q1 2025).